Linvoseltamab
Antibody therapy shows promise against multiple myeloma
Antibody therapy shows promise against multiple myeloma Researchers have made promising progress against multiple myeloma using an immune and cancer cell-targeting antibody therapy called linvoseltamab, which eradicates residual traces of the blood cell cancer in patients. The interim results from a clinical trial show that none of the 18 patients who completed up to six […]
🏥 Health